Catalent Completes Acquisition of Majority Share in Chinese Softgel Business
30 July 2013 --- Catalent Pharma Solutions, the global leader in drug development solutions and advanced delivery technologies for pharmaceutical, biologic and consumer health products, today announced that having met the required regulatory approvals, it has completed the acquisition of a majority share in Haining-based, privately held Zhejiang Jiang Yuan Tang Biotechnology Co., Ltd.
The business produces nutritional softgel products for Chinese and Asia Pacific markets, and employs 120 staff.
Having previously announced the appointment of Mr. Weiyan “Jackson” Zhu as Country General Manager for China, Catalent will initially concentrate on the growing vitamins, minerals and supplements market in Asia-Pacific, whilst simultaneously investing in its facilities and working with regulators to expand their business into OTC and prescription softgel manufacturing for the region.
